[ Price : $8.95]
Federal Register Notice: FDA proposes to withdraw ANDA approval for methylphenidate hydrochloride extended-release tablets, and is...[ Price : $8.95]
Federal Register Notice: FDA proposes to withdraw ANDA approval for methylphenidate hydrochloride extended-release tablets, and is...[ Price : $8.95]
Federal Register Notice: FDA proposes to amend its regulations to add three drugs to the list of drug products that have been with...[ Price : $8.95]
Federal Register Final Order: FDA classifies as Class 2 (special controls) the upper extremity prosthesis including a simultaneous...[ Price : $8.95]
Virtus Pharmaceuticals files suit against FDA in middle Florida federal court seeking an order barring enforcement action against ...[ Price : $8.95]
Federal Register Notice: FDA issues a priority review voucher to Sarepta Therapeutics after determining its NDA for Duchenne muscu...[ Price : $8.95]
Federal Register proposed rule: FDA proposes to implement provisions requiring electronic submission of the device label and packa...[ Price : $8.95]
Federal Register Final Order: FDA classifies the apical closure device into Class 2 (special controls).